http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102657858-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f1f9d5a596548b896e53017953aa026
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
filingDate 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fb32cd29a501793973da3508f228794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d9ba15d28f1dbb0e7bca70cc56e47dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e04caa379aca2bc4b7c897b89ebe2dcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79178f1a0ff917882483ed8580a4d62a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d52c0d2741d16af28916d81af7826167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d768c98e997336b12640ce784a56686b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bb1fa4517f6043b0bb7f47c9747dcaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b035875b9e98354cbc3049a91daff14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb5fe8b12e07323a2a85ef6f813711b6
publicationDate 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102657858-B
titleOfInvention Method for preparing enterovirus vaccines
abstract The invention provides a method for preparing enterovirus vaccines, which uses gerbil muscle cells as stroma cells of virus culture. The method uses the gerbil muscle cells as the stroma cells for culturing EV71 or CoxA16 viruses, growth titer of the EV71 or CoxA16 viruses on the cells is high, and liquid collection can be conducted repeatedly. The cells can be performed with passage repeatedly, muscle cell strains can be built for production of vaccines, and consumption of gerbil is saved. The cells are primary cells so that the problems that passage cell deoxyribonucleic acids (DNA) are difficult to process and the like do not exist. The vaccine production process is relatively easy, purification is convenient, and the prepared vaccines are safe and reliable when used for vaccination of infants.
priorityDate 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450254702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23705
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID33758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID33758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493484

Total number of triples: 30.